True Health Diagnostics Successfully Completes First Year of Corporate Integrity Agreement

FRISCO, Texas, Aug. 25, 2016 — True Health Diagnostics, a health services company, today announced the successful completion of its first year under a Corporate Integrity Agreement, including an independent review of its compliance program and a comprehensive report to the Office of Inspector General.

True Health voluntarily agreed to operate under a five-year CIA after it purchased assets from a competitor that was part of a federal enforcement action.

“True Health stepped forward and offered to operate with a CIA, because the actions of a couple of companies were reflecting poorly on our entire industry,” said Chris Grottenthaler, CEO of True Health Diagnostics. “We took on the CIA to make it crystal clear that compliance and integrity would be pillars of our business.”

Health care companies with Corporate Integrity Agreements (CIA), established under the auspices of the U.S. Office of Inspector General, must put in place a robust compliance program that includes, among other actions: establishing a confidential disclosure program; implementing a training program for every employee; and retaining an independent review organization to conduct annual reviews.

“We believe that the information we provide about chronic diseases can make people healthier, can change lives,” Grottenthaler said. “To trust a diagnosis, a patient or doctor has to be able to trust the company that provides it – that’s why a strong compliance program is vital.”

About True Health Diagnostics

True Health Diagnostics is a clinical and health services management company providing best-in-class diagnostics and disease-management solutions that empower medical specialists to achieve better patient outcomes. The company specializes in innovative biomarkers, enabling healthcare providers to more accurately diagnose, manage, and slow the progression of the major chronic diseases affecting our society. True Health’s clinical services deliver personalized, comprehensive patient information focused on further fighting the progression of chronic disease. As the largest company in its sector, True Health leverages its state-of-the-art laboratory, robust data sources, innovative techniques, and interdisciplinary medical teams to deliver the industry’s most advanced, reliable and effective clinical diagnostics and disease-management solutions. More information is available at